Laura White
Profiles

Laura Forsberg White, PhD

Professor, Biostatistics - Boston University School of Public Health

617-358-2519
lfwhite@bu.edu
Crosstown Center - 312
View Full Profile at BUMC

Biography

Laura Forsberg White, PhD, is a Professor of Biostatistics at Boston University. She is interested in developing statistical tools to better understand the transmission dynamics and epidemiology of infectious diseases and substance use disorders. She has developed methods to estimate transmission parameters. Her work involves the development of novel methodologies for the detection of disease outbreaks, as well as the application statistical methods for public health surveillance systems, including spatial statistics and time series. Dr. White's work includes applications and collaborations in Tuberculosis, Hepatitis C, HIV, and substance use disorders. She works with several large international studies focused on Tuberculosis and is part of the Boston Providence Center for AIDS Research. She leads her own research group focused on developing statistical methods to better understand TB transmission and burden, as well as Covid-19 transmission dynamics. At SPH, she teaches Public Health Surveillance: A Methods Based Approach (BS 728).

Other Positions

  • Adjunct Assistant Professor, Biostatistics - Harvard T.H. Chan School of Public Health

Education

  • Harvard University, PhD Field of Study: Biostatistics
  • Utah State University, BS Field of Study: Mathematics
  • Harvard School of Public Health, SM/ScM Field of Study: Biostatistics

Websites

Publications

  • Published on 10/18/2023

    Albright C, Van Egeren D, Thakur A, Chakravarty A, White LF, Stoddard M. Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion. PLoS One. 2023; 18(10):e0292099. PMID: 37851632.

     Read At: PubMed
  • Published on 10/13/2023

    Tilhou AS, Murray E, Wang J, Linas BP, White L, Samet JH, LaRochelle M. Trends in buprenorphine dosage and days supplied for new treatment episodes for opioid use disorder, 2010-2019. Drug Alcohol Depend. 2023 Nov 01; 252:110981. PMID: 37839942.

     Read At: PubMed
  • Published on 9/26/2023

    Wang J, Doogan N, Thompson K, Bernson D, Feaster D, Villani J, Chandler R, White LF, Kline D, Barocas JA. Massachusetts Prevalence of Opioid Use Disorder Estimation Revisited: Comparing a Bayesian Approach to Standard Capture-Recapture Methods. Epidemiology. 2023 Nov 01; 34(6):841-849. PMID: 37757873.

     Read At: PubMed
  • Published on 8/9/2023

    Barber LE, Bertrand KA, Sheehy S, White LF, Roy HK, Rosenberg L, Palmer JR, Petrick JL. Aspirin and nonaspirin nonsteroidal antiinflammatory drug use and occurrence of colorectal adenoma in Black American women. Int J Cancer. 2023 Dec 15; 153(12):1978-1987. PMID: 37555819.

     Read At: PubMed
  • Published on 7/5/2023

    Barber LE, VoPham T, White LF, Roy HK, Palmer JR, Bertrand KA. Circadian Disruption and Colorectal Cancer Incidence in Black Women. Cancer Epidemiol Biomarkers Prev. 2023 Jul 05; 32(7):927-935. PMID: 36409509.

     Read At: PubMed
  • Published on 6/6/2023

    Bayly H, Stoddard M, Egeren DV, Murray EJ, Raifman J, Chakravarty A, White LF. Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemic. Res Sq. 2023 Jun 06. PMID: 37333276.

     Read At: PubMed
  • Published on 4/16/2023

    Van Egeren D, Stoddard M, White LF, Hochberg NS, Rogers MS, Zetter B, Joseph-McCarthy D, Chakravarty A. Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines (Basel). 2023 Apr 16; 11(4). PMID: 37112765.

     Read At: PubMed
  • Published on 4/6/2023

    Stoddard M, Yuan L, Sarkar S, Mangalaganesh S, Nolan RP, Bottino D, Hather G, Hochberg NS, White LF, Chakravarty A. Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy. Vaccines (Basel). 2023 Apr 06; 11(4). PMID: 37112718.

     Read At: PubMed
  • Published on 2/8/2023

    Petros BA, Turcinovic J, Welch NL, White LF, Kolaczyk ED, Bauer MR, Cleary M, Dobbins ST, Doucette-Stamm L, Gore M, Nair P, Nguyen TG, Rose S, Taylor BP, Tsang D, Wendlandt E, Hope M, Platt JT, Jacobson KR, Bouton T, Yune S, Auclair JR, Landaverde L, Klapperich CM, Hamer DH, Hanage WP, MacInnis BL, Sabeti PC, Connor JH, Springer M. Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations. Clin Infect Dis. 2023 Feb 08; 76(3):e400-e408. PMID: 35616119.

     Read At: PubMed
  • Published on 2/8/2023

    Bouton TC, Atarere J, Turcinovic J, Seitz S, Sher-Jan C, Gilbert M, White L, Zhou Z, Hossain MM, Overbeck V, Doucette-Stamm L, Platt J, Landsberg HE, Hamer DH, Klapperich C, Jacobson KR, Connor JH. Viral Dynamics of Omicron and Delta Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants With Implications for Timing of Release from Isolation: A Longitudinal Cohort Study. Clin Infect Dis. 2023 Feb 08; 76(3):e227-e233. PMID: 35737948.

     Read At: PubMed

View 156 more publications:View Full Profile at BUMC

News & In the Media

View all profiles